triethylenemelamine has been researched along with Anemia in 5 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
TAYLOR, L | 1 |
MOLANDER, DW | 1 |
LADUE, JS | 1 |
BRIDGES, JB | 1 |
BRIDGES, JM | 1 |
EDELSTYN, GJ | 1 |
LYONS, AR | 1 |
BRODY, JI | 1 |
BEIZER, LH | 1 |
Silver, RT | 1 |
1 review available for triethylenemelamine and Anemia
Article | Year |
---|---|
The treatment of chronic lymphocytic leukemia.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Ag | 1969 |
4 other studies available for triethylenemelamine and Anemia
Article | Year |
---|---|
IDIOPATHIC AUTOIMMUNE HEMOLYTIC ANEMIA. RESPONSE OF A PATIENT TO REPEATED COURSES OF ALKYLATING AGENTS.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune | 1963 |
CHRONIC LEUKEMIA.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alkylating Agents; Anemia; Anemia, Hemolytic, | 1964 |
FEOTAL LIVER SUSPENSIONS IN THE TREATMENT OF MARROW APLASIA.
Topics: Anemia; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Fetus; Hemoglobi | 1965 |
ALTERATION OF BLOOD GROUP ANTIGENS IN LEUKEMIC LYMPHOCYTES.
Topics: ABO Blood-Group System; Anemia; Anemia, Aplastic; Antigens; Blood Group Antigens; Child; Chlorambuci | 1965 |